INTRODUCTION:

The Several, effective uses of surfactants are based on the multiplicity of their molecular characteristics, that is, they are formed by the water-loving polar head group and the non-water-repellent tail group. Many variations are possible in the head group and in the tail of the surfactants group. For example, the primary group may be anionic, cationic, twitter ionic, or non-ionic. It can be small and compacted in size or series of oligomeric¹. The tail group can be hydrocarbon, fluorocarbon, or siloxane. It can contain straight chains, branch structures or rings, multiple chains, etc. Surfactant molecules with two headgroups (ball surfactants) are also available. In addition, head groups and tail groups can be polymeric in character, as in the case of block copolymers. This diversity in the cellular structure of biological agents allows for a wide range of variations in their solution and in interactions with humans.

It is only natural that one would like to find a link between the molecular structure of surfactant and its physicochemical action so that surfactants can be synthesized or selected according to the specific application offered. Therefore, there has been a growing interest in the development of a drug delivery system that is not only powerful but also defines the environment ². In recent years, nanotechnology has focused heavily on the numbers of researchers around the world in terms of its importance in increasing efficiency, specificity, tolerance, and therapeutic index of complementary drugs. Several techniques have been proposed such as micronization, complexation, solid solution formulation, microemulsification, and novel drug delivery systems including nanoparticles, lipid-based vesicles, and micelles³. Among these approaches, polymeric micelles (PMs) have received much attention over the past two decades as a multidisciplinary delivery system based on nanotechnology of water-soluble chemicals. According to IUPAC, polymeric micelles are a systematic auto- Assembly composed of liquids and composed of amphiphilic macro molecules typically in amphiphilic di or tri block⁵. Polymers are made of solvophilic and solvophobic blocks. Amphibian block copolymers can be used to form polymeric micelles. Micelles has a basic shell structure. The core contains a hydrophobic tail that can be used to load an effective therapeutic drug. The shell mixes with the solvent and forms nano-stable nano particles in Liquid⁴. Width of polymeric microns ranging from 10to 100 nm. The molecular weight of the amphiphilic block co-Polymer, the number of amphiphile compounds, the properties of the hydrophilic and hydrophobic chains and the preparation process are factors that affect the size of the Polymeric micelles⁶. Suitable copolymers of amphiphilic block are obtained by synthesis synthesis by changing block size, total molecular weight, and chemical composition. By adjusting the composition of amphiphilic copolymers, the size and morphology of emerging polymeric micelles can be easily controlled ^7. The micellar spine produces a hydrophobic domain that can be used to process hydrophobic associations. Most water-soluble drugs can be easily incorporated into a polymeric micronle core to overcome melting problems. Melting instability often results in better oral availability of hydrophobic drugs. Active micelles tend to disperse in regeneration resulting in the processing of cell cells⁸. Polymeric micmelles are more stable in terms of purification than active micelles and are therefore showing less cytotoxicity. Hydrophilic shell and nanoscopic size prevent the release of micelles by filtration or filtration⁹. This helps to increase the blood circulation of the drug. Also, the shell stabilizes the micelle, interacting with plasma proteins and cell membranes and its environment regulates the distribution of cargo. Nanoscopic size reduces the risk of embolism in the capillaries, unlike large drug carriers¹².It also likes to absorb some of the intestinal system. Along with these features, low toxicity and rapid absorption of polymeric micelles into the body makes them suitable for internal drug delivery systems. Furthermore, there is no need for modification of the chemical structure of drugs. Polymeric micmelles provide access to guidance due to the large volume of internal drug loads and symptoms of a different body condition due to their size¹⁵. The breakdown of blockchain block copolymers and on ipheriphery peptides reveals a number of micelles that alter biological features that can be used in the delivery of receptor-mediated and gene-targeting drugs¹⁴. Immuno micelles, another form of identification, are synthesized by combining anti-monoclonal antibody molecules into surfactants or polymeric micelles that exhibit high specificity and binding. Polymeric micelles can lead to the construction of 'smart cars' by using energy-sensitive copolymers (pH, temperature sensitive). Such smart vehicles are currently being tested to determine the availability of controlled drugs. ¹⁸

Based on the type of molecule that controls the separation of the primary component from the aqueous environment, polymeric micelles can be divided into three main phases, namely, micelles formed by hydrophobic bonds, those from electrostatic bonds (polyion complex micelles), and micelles from Complexation of steel. ²⁰

Normal^2,10

In aquatic environments the shell and shell combine Hydrophobically to form micelles. One of the simple amphiphilic block copolymer, poly (ethylene oxide) -b- poly (propylene oxide) -b-poly (ethylene oxide), forms micelles as a result of hydrophobic interactions.

Polyion micelles complex (PICMs)

Polyion micelles complex are formed by electrostatic interactions between two opposing moitions. The electrostatic force and the van der Waals force contact control the formation and size of charged micelle coronas. PICMs have a variety of features, such as an easy-to-use route, easy integration with a water repellent, structural stability, drug loading capacity, and long-term blood circulation. Michelle is prepared in liquid media without using organic solvent. This will allow you to eliminate side effects, which can be caused due to residual organic solvent. The complex polyion micelles complex can capture many therapeutic agents through the combination of electrostatic, hydrophobic hydrogen. These therapeutic agents are released from the hole with a suitable trigger. The Polyion complex micronle can be used for the delivery of charged drugs, antisense oligonucleotides, DNA and enzymes.

Unconnected polymeric micelle microbes are mixed together^17,20

In non-bonded polymeric components, polymeric micelles can be prepared in the absence of a co-polymer block where the applied energy is applied by inter polymer hydrogen bonding complexation.Core and corona are not connected by a homopolymer chain link by hydrogen bonding or metal ligand contact, hence the name of the unrelated polymeric micelles.

Benefits of Polymeric Micelle^19-25

Polymeric micelles has some advantages in the medical field that explain it this way.

1. High structural stability is the first advantage of polymeric micelles. Polymeric microns maintain high structural strength due to the adhesion of polymer chains on the inner surface. The high structural stability of polymeric micelles is an important key to the delivery of in vivo in micellar forms and at the same time eliminates the potential contribution of single polymer chains to drug delivery.

2. Polymeric micelles can be used safely in parental management than standard solubilizing agents such as polyethoxylated Castor oil (Cremophor EL) or polysorbate 80. Consider a variety of non-soluble chemicals.

3. Mathematically stable, polymeric micelles separate slightly, thus extending blood circulation times. Their cores are generally larger than the active Micelles thus improving their solubility of hydrophobic drugs.

4. Polymeric micelles with a diameter of 10nm to 100nm are considered suitable for achieving a stable, long-term circulatory system. Alternatively, the small size of polymeric micelles has great benefits in sterilization programs in drug production. So polymeric micelles are actually free of contaminants of small particles.

Improve the integration of biocompatibility, robustness, high in vitro and in vivo stability.

6. Polymeric micelles can incorporate large amounts of hydrophobic molecules into the internal environment of Micelles, and at the same time, Micelles can maintain water solubility by blocking the chemical bonding of internal Hydrophobic cores with an outer layer of Shell that acts as a barrier against inter Micell bonding.

7. The engineering of its overgrowth with various ligands and cells entering cells that contribute to the specific direction and accumulation of cells.

8. Some polymeric micelles are designed to overcome drug-efflux or resistance by inhibiting the transport of P-Glycoprotein (PGP) or the transport of Multi-Drug Resistance Protein 2 (MDRP 2).

9. These compounds can be incorporated into the inner core of the micelle by chemical bonding to the inner-inner polymer Block or by physical contact due to the hydrophobic interaction between the adhesive drug molecules and the hydrophobic Inner-core forming a polymer block.

10. Generally, polymeric surfactants are known to be less toxic than low-density Surfactants, such as sodium dodecyl sulfate.

Disadvantages of Polymeric Micelle:

1. The first disadvantage of polymeric micelles is that very high levels of polymer chemistry are required in polymeric micelle studies.

2. The second disadvantage of Polymeric micelle systems is the immature technology of drug delivery in a practical way.

3. The third disadvantage is the slow explosion of polymeric carrier systems than those of low-weight drugs. This effect is due to differences in Extravasation methods between low molecular weight drugs and polymeric carrier Systems.

Ppolymeric Cycle Methods^11-22

By using self-Assembly block copolymers there are two common ways to prepare polymeric micelles. Alternative direct dispersion method or organic-Solvent-free method and alternative solvent or solvent disposal method or 'solvent-switch' method.

Organic-solvent-free method or direct dispersion method:

Direct dissolution of the drug and copolymer in water by stimulation, heat, ultrasound treatment that assists melting. It involves the direct elimination of amphiphilic copolymer and drugs in water to prepare drug-laden micelles. But low drug load is a disadvantage of this method. The temperature rises to form a form of micelles with no water in the components that make up the core. The copolymer and the drug are dissolved separately in an aqueous solution, and both solutions are then mixed together to form micelles. Eg: Novel Biodegradable Polylactide / poly (ethylene glycol) Micelles developed by Direct Dissolution is a method of controlling the delivery of cancer drugs that show great potential for hydrophobic drug administration.

Solvent evaporation or distribution method:

In this way, a flexible organic solvent is used to dissolve the block copolymer and the drug because most amphiphilic block copolymers do not dissolve directly in water. This method can be used only when both the copolymer and the drug are dissolved in a common solvent and when they do not dissolve in water. A thin film of copolymer and the drug is obtained after the solvent has been removed by vapor. Micelles loaded with the drug is obtained by re-forming the film in water. Eg: Paclitaxel-loaded micelles are processed by solvent evaporation process.

Ial Dialysis method:

When building blocks are long and have a large hydrophobic number, the above methods are not suitable for preparation. In these cases, a dialysis procedure may be used. The drug in the copolymer is mixed together in an organic solvent solution above is poured into a dialysis bag in a dialysis bag It is placed in a container containing water. This solution and inlet and outlet. The detoxification process takes more than 36 hours for proper drug loading.

Use of Polymeric Micelles:

Solubilization:

The Micellar spine is an excellent site for the insertion of water-soluble hydrophobic molecules. Hydrophobic molecules can be synthesized by interacting with Block copolymers or physically embedded in a hydrophobic molecule of micelles. It is often known that intestinal particle exposure is significantly affected by the particle size. Nano-polymeric-sized micano scales increase absorption. The absorption rate depends on the micellization process, temperature, the interaction between the drug and the basic building block, the hydrophobic block chain length and the polymer filter

Delivery Delivery of drugs to the brain

The formation of the blood-brain barrier is very complex, so it must be carefully investigated in order to transport the drug to the brain. In other neurodegenerative disorders such as Parkinson's, Alzheimer's disease, Barrier brain barriers are disrupted by drug withdrawal (2). Improving the delivery of therapeutic drugs to the brain especially the two methods are set using polymeric micelles(9). The first method is proposed on the basis of mutations of antibodies polymer micelles or ligand molecules capable of altering transcytosis in all microvessel endothelial brain cells, which contain BBB. The second method uses Plolyonic block copolymers to block drug efflux systems, in particular, Pgp, and specifically selects BBB availability on Pgp substrates (15). For example, poloxamer micelles are bound by antibodies and improve the distribution of haloperidol in the brain, this improves drug performance. Another example is that Pluronic unimers assist in the entry of molecules such as rhodamine, digoxin, doxorubicin in to bovine mammary epithelial cell by inhibiting P-gp.

Formation of an antiseptic agent:

In immobilized AIDS, surgery, cancer patients, in the event of a fungal infection, there should be a safe and effective method of delivery of chemotherapeutic agents. For example, amphotericin B has a low affinity for micelle polymeric content. To avoid this problem, and to increase its melting point, the side chains were bound with methoxy-PEO-b-Poly (L-aspartate), a block forming the substance.

Passive drug targeting to solid solid:

Drug administration at certain sites will minimize adverse reactions, as action will be limited to certain sites. Polymeric micmelles can be used to identify specific sites and can be a promising baptismal candidate for the delivery of hard tissue. Negative targeting is defined as the way in which the physical and chemical properties of a carrier systems increase the targeting / unlimited amount of drug delivered. The high concentration of the drug in tissues that exhibit EPR activity is based on the production and protection of chemicals such as vascular endothelial growth factor bradykinins, nitric oxide, enzyme collagenase, peroxynitrite

Effective drug administration:

The principle of effective identification is to increase the delivery of drugs to the target areas through specific interactions or by means of heating and sonication i.e. signals used locally. Effective guidance can be obtained by identifying diseased cell cells with polymeric micelles, above expressed at the diseased site or by ligand-receptor or antigen-antibody interactions. The ligand attachment to Milles's polymeric surface increases cellular uptake through the interaction between the ligand and its highly exposed receptors at the surface of the cell. The ligand includes a pair of polymeric micelles and polymeric immunomicelles, epidermal.

Directing polymeric micelles is usually obtained by one of the following methods; improved strength and retention capacity, stimulant sensitivity, fusion of ligand molecules directly to the micelle surface, or by attaching monoclonal antibodies to the micelle corona, meaning 58 active signaling using immune micelles.

Improved Final Final Resilience^23-25

Due to their nanoscopic size, polymeric micelles accumulate sparingly in the gaps between various areas of disease by destroying leaky capillaries (especially solid tumors). They have also been shown to distribute some of the cytoplasmic organelles, as well as non-invasive tissues, infected areas, 59 inflammatory sites that have a protective effect. Since polymeric micellar drug carriers cannot pass through the walls of normal blood vessels, the reduced side effects of the drug are evident. In tumor neovasculature, there is an undeveloped lymphatic drainage system that results in improved storage of polymeric micelles within the solid tumor as the micelles are not well defined. This feature allows for a longer distribution of polymeric micelles in the 60 circulatory system during administration. Because of these factors, it is possible to achieve random drug identification using polymeric micelles. Vetvicka and his colleagues developed a micellar drug delivery system designed to increase blood circulation by 62 times and increase the effectiveness of the EPR effect. They prepared doxorubicin conjugated poly (ethylene oxide) -Block-poly (allyl glycidyl ether) micellar system that proliferated for a long time and extracted doxorubicin positively from the plant site due to the acidic pH present in the Tumor site.

Incentives-Sensitivity:

With proper drug administration, there should be no extraction of the drug from the micelle during the cycle. The drug should be released only after the polymeric microns have accumulated in the target tissues, using other internal substances such as a specific pH enzyme, etc. Or with an external trigger that includes temperature, light, ultrasound or magnetic energy Depending on the stimulus used various responses can be seen including structural disturbances, changes in composition, volume, fullness levels, hydration status, inflammation / collapse, hydrophilic / hydrophobic, or associated changes. Damage to micelles as a result of stimuli that occur internally or externally is called ‘stimulant sensitivity’ or ‘environmental sensitivity’ of micelles.

Aidid-Sensitivity Polymeric Micelles:

There are many pH gradients present in normal and pathophysiological regions within the body. Micelles of polymeric-sensitive or pH-sensitive polymeric use this difference in pH in directing drugs. In the tissues and tissues the pH has a low acidity (pH approx. 6.8). This is a slightly lower value compared to the pH of blood and normal tissues (pH approx. 7.4). Micelles can also be taken up to the cell through the process of endocytosis and may enter cell organelles such as endosomes, lysosomes, etc.

The two main methods used to create pH-sensitive systems are: the involvement of a respectable group in the copolymer, and the inclusion of unstable label connections in acidic conditions. The combination of suitable groups such as amines, carboxylic acids in the backbone of the copolymer leads to a modification of the melting of the polymer when exposed. This can actually disrupt micellar formation. The incorporation of acid-labile bonds, similar to the benzoic imine compound, in polymeric structures has been shown to create a change in micellar integrity or complete destruction of the micellar structure when these polymers meet low pH.

Thermosensitive Polymeric Micelles:

Thermosensitive micelles exert a structural change in response to an increase in temperature, leading to drug deposition and easier drug depletion by cells. Thermosensitive polymers at a certain temperature produce a rapid phase change that is accompanied by a sudden change in resolution. This transfer temperature is referred to as the temperature of the critical solution. Liu et al. demonstrated the use of poly (N-Isopropylacrylamide-co-acrylamide) -b-poly (D, L-lactide) 68 copolymer in the plant direction of docetaxel. They found that hyperthermia significantly improved the identification function of drug-laden micelles and helped to reduce drug toxicity.

REFERERENCE:

1. Mourya V. K., Inamdar Nazma, Nawale B.R., Kulthe S. S. Polymeric Micelles: General Considerations and their Applications. Indian Journal of Pharmaceutical Education and Research. 2011; 45

2. Mathew Chinju, Sebastian Kripa, Daisy P. A, R. Praveen Raj. A Comprehensive Review on Polymeric Micelles, Inst. J. Pharm. Sci. Rev. Res. 2020; 61(2): 08,36-39, www.globalresearchonline.net

3. Xu Wei, Ling Peixue, Zhang Tianmin. Review Article Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs, Hindawi Publishing Corporation Journal of Drug Delivery. 2013, Article ID 340315, 15 pages.

4. Nagaich Upendra, Deepak Payal, Sharma Aman, Gulati Neha, Chaudhary Amit. Review Article polymeric micelles: potential drug delivery devices. Indonesian J. Pharm. 2013; 24(4): 223 – 238

5. Wakaskar Rajesh R, Polymeric Micelles and their Properties, Article in Journal of Nanomedicine and Nanotechnology, January 2017.

6. Kulthe Sushant S., Choudhury Yogesh M., Inamdar Nazma N., Mourya Vishnukant. Polymeric micelles: authoritative aspects for drug delivery. Designed Monomers and Polymers. 2012; 15(5): 465–521.

7. Powar Priyatama V, Sharma Padmini H. Review article on Polymeric micelle as multifunctional therapeutics. Journal of Innovations in Applied Pharmaceutical Science. 2016; 1 (1): 24-33.

8. Elena V. Batrakova, Tatiana K. Bronich, Joseph A. Vetro and Alexander V. Kabanov. Ordanini Stefania and Cellesi Francesco. Complex Polymeric Architectures Self-Assembling in Unimolecular Micelles: Preparation, Characterization, and Drug Nanoencapsulation. Pharmaceutics. 2018; 10: 209.

9. Salimi Anayatollah, Zadeh Behzad Sharif Makhmal, Mahmoudabadi Najme. Formulation and evaluation of polymeric micelle drug delivery system of celecoxib to improve the oral absorption. European Journal of Biomedical and Pharmaceutical Sciences. EJBPS. 2014; 1(2): 372-385.

10. Suroshe Samiksha, Nerkar Pankaj, Patil Kanchan, Chalikwar Shailesh. Breast cancer: Recent review on micelles as nano-carriers for treatment. Indo American Journal of Pharmaceutical Research. 2019.

11. Zana R. Dynamics of surfactant self-assemblies-Micelles, microemulsions, vesicles, and lyotropic Phases. Boca Raton, FL33487-2742: CRC Press, Taylor and Francis Group; 2005. Pp. 2-16.

12. Mahmud A, Xiong XB, Aliabadi HM, Lavasanifar A. Polymeric micelles for drug targeting. J Drug Target 2007; 15:553-84.

13. Adams ML, Lavasanifar A. Kwon GS. Mini review Amphiphilic block copolymers for drug delivery. J. Pharm. Sci. 92, 2003, 1343−1355.

14. Rubetskoy VS. Polymeric micelles as carriers of diagnostic agents. Adv Drug Deliv Rev. 37, 1999, 81-88.

15. Nangare K A, Powar S D, Kate V K, Nandgude T D, Payghan S A. Exploring the State-of-Art of Nanosuspensions: Theoretical Aspects, Formulation and Characterization. Inventi: PNDDS/25746/18.

16. L. Bromberg. Polymeric micelles in oral chemotherapy. Journal of Controlled Release. 2008; 128(2): 99–112.

17. L. Bromberg, M. Temchenko, V. Alakhov, and T. A. Hatton. Bioadhesive properties and rheology of polyether-modified Poly(acrylic acid) hydrogels. International Journal of Pharmaceutics. 2004; 282(1-2): 45–60.

18. Sarda Akash, Powar Sayali, Nangare Kavita, Payghan S A. Formulation and Characterization of Sublingual Tablet for Rapid Absorption and Taste Masking of Tenoxicam. Inventi Rapid: Pharm Tech. 2017; (1):1-14.

19. Adams ML., Lavasanifar A. Kwon GS. Minireview amphiphilic block copolymers for drug delivery. J. Pharm. Sci. 2003; 92: 1343−1355.

20. Dhembre GN., Moon RS., Kshirsagar RV. A review on polymeric micellar Nanocarriers. IJPBS. 2011; 2: 109-116.

21. Nangare K A, Powar S D, Kate V K, Nandgude T D, Payghan S A., Exploring the State-of-Art of Nanosuspensions: Theoretical Aspects, Formulation and Characterization. Inventi: PNDDS/25746/18.

22. Jones MC, Leroux JC. Polymeric micelles a new generation of colloidal drug carriers. European Journal of Pharmaceutics and Biopharmaceutics. 1999; 48:101–11.

23. K. A. Nangare, S. D. Powar, S. A. Payghan: Nanoerythrosomes: Engineered Erythrocytes as a Novel Carrier for the Targeted Drug Delivery. Asian Journal of Pharmaceutics. 2016; 10 (3):223-233.

24. Nangare Kavita, Powar Sayali, Santosh Ambadas Payghan. Design of Three-factor Response Surface Optimization of Camouflaged Capecitabine Nanoerythrovesicles. Asian Journal of Pharmaceutics 2016; 10 (4): 306-321.

25. Swapnil Chopade, Sheeba Khabade, Kavita Nangare, Powar Sayali, Bagal Vinay. Box–Behnken design for preparation of Tenoxicam- nanogel for ocular delivery: Optimization, in vitro Coneal permeation. 2018; 9(4):486-499.

Received on 25.03.2021 Modified on 18.10.2021

Asian J. Res. Pharm. Sci. 2022; 12(1):37-41.

DOI: 10.52711/2231-5659.2022.00007